What Is IGF-1 LR3 Used For in Research?
IGF-1 LR3 (Long Arginine 3 Insulin-like Growth Factor-1) is an engineered polypeptide analog widely investigated in cell biology, metabolic signaling, and tissue differentiation research. Researchers routinely utilize this compound to explore insulin-like growth factor receptor type 1 (IGF-1R) activation, intracellular phosphorylation cascades, and cell survival mechanisms without the interference of endogenously secreted binding proteins. Designed strictly for laboratory investigation, IGF-1 LR3 provides an enhanced tool for probing anabolic pathways in vitro and in preclinical animal models.
Quick answer
IGF-1 LR3 (Long Arginine 3 Insulin-like Growth Factor-1) is an engineered polypeptide analog widely investigated in cell biology, metabolic signaling, and tissue differentiation research. Researchers routinely utilize this compound to explore insulin-like growth factor receptor type 1 (IGF-1R) activation, intracellular phosphorylation cascades, and cell survival mechanisms without the interference of endogenously secreted binding proteins. Designed strictly for laboratory investigation, IGF-1 LR3 provides an enhanced tool for probing anabolic pathways in vitro and in preclinical animal models.
Key takeaways
- In modern cell biology and preclinical research, **what is [IGF-1 LR3](/research-peptides/igf-1-lr3) used for** centers on investigating insulin-like growth factor receptor type 1 (IGF-1R) signaling dynamics, cellular proliferation, protein translation kinetics, and satellite cell differentiation.
- [IGF-1 LR3](/research-peptides/igf-1-lr3) is an 83-amino-acid recombinant analog of human IGF-1.
- In cell culture environments, [IGF-1 LR3](/research-peptides/igf-1-lr3) is primarily deployed to measure cell proliferation, survival rates, and metabolic uptake rates.
- In preclinical animal studies, primarily involving rodent models, researchers evaluate the downstream systemic and localized effects of [IGF-1 LR3](/research-peptides/igf-1-lr3) administration.
Direct Overview: What Is IGF-1 LR3 Used For in Laboratory Settings?
In modern cell biology and preclinical research, **what is IGF-1 LR3 used for** centers on investigating insulin-like growth factor receptor type 1 (IGF-1R) signaling dynamics, cellular proliferation, protein translation kinetics, and satellite cell differentiation. Because of structural modifications that lower its affinity for IGF-binding proteins, researchers utilize IGF-1 LR3 to evaluate sustained receptor autophosphorylation, downstream PI3K/Akt/mTOR pathway activation, and hyperplastic response markers without rapid native clearance.
As a specialized research reagent, IGF-1 LR3 is deployed in controlled in vitro culture systems and preclinical in vivo studies. It serves as a benchmark ligand for evaluating intracellular signaling cascades, cell survival under hypoxic or nutrient-deprived stress, and cellular differentiation endpoints. For researchers managing larger assay volumes or comparative screening programs, sourcing from specialized platforms like PX1 Research ensures consistent lot-to-lot analytical purity across all experimental protocols.
Molecular Architecture and Receptor Affinity Kinetics
IGF-1 LR3 is an 83-amino-acid recombinant analog of human IGF-1. The native peptide consists of 70 amino acids, but the LR3 variant incorporates two distinct modifications: a substitution of glutamic acid with arginine at position 3 (hence 'Arg3' or 'R3'), and a 13-amino-acid N-terminal extension ('Long'). In physiological environments, native IGF-1 binds tightly to endogenous IGF-binding proteins (IGFBPs), which sequester the hormone and modulate its biological half-life and bioactivity.
The structural alterations in IGF-1 LR3 drastically reduce its affinity for IGFBPs by up to 100-fold compared to wild-type IGF-1. Consequently, when introduced to cell cultures or model organisms, a significantly higher concentration of free, unbound ligand is available to engage membrane-bound IGF-1R complexes. In vitro assays demonstrate that this reduced binding protein affinity translates to prolonged biological activity, enabling investigators to observe sustained receptor activation and extended activation of downstream effectors such as IRS-1, Akt (Protein Kinase B), and p70S6K.
In Vitro Research Applications and Cell Line Models
In cell culture environments, IGF-1 LR3 is primarily deployed to measure cell proliferation, survival rates, and metabolic uptake rates. Immortalized skeletal muscle cell lines, such as C2C12 myoblasts, serve as primary in vitro models. Researchers introduce IGF-1 LR3 to myoblast cultures to observe the acceleration of myoblast fusion into mature myotubes, analyzing markers of myogenesis such as myogenin and myosin heavy chain (MHC) expression.
Beyond skeletal muscle models, IGF-1 LR3 is utilized in cardiac myocyte studies, chondrocyte proliferation assays, and neuronal cell cultures. In these settings, investigators probe how IGF-1R autophosphorylation inhibits apoptotic pathways through the downregulation of pro-apoptotic proteins like Bad and caspase-3. Because IGF-1 LR3 does not readily bind to IGFBP-3 or IGFBP-5, culture media containing serum supplements do not rapidly neutralize the peptide's activity, allowing for lower effective concentrations in long-term cell survival assays.
Preclinical Animal Models and In Vivo Endpoints
In preclinical animal studies, primarily involving rodent models, researchers evaluate the downstream systemic and localized effects of IGF-1 LR3 administration. Rodent models of muscle wasting, denervation, or metabolic dysfunction are frequently utilized to measure alterations in protein synthesis rates versus proteolysis. Scientists assess changes in total RNA-to-protein ratios, skeletal muscle fiber cross-sectional area, and satellite cell recruitment following treatment protocols.
Preclinical trials also analyze systemic metabolic responses, such as glucose uptake dynamics in peripheral tissue and serum insulin level fluctuations. Because IGF-1 LR3 interacts with both IGF-1R and, at high concentrations, insulin receptors, preclinical experiments carefully map glucose clearance rates and glycogen synthase activation. These preclinical rodent studies help elucidate the cellular signaling networks responsible for tissue repair, nutrient partitioning, and hypertrophic adaptive responses under rigorous experimental conditions.
Comparative Analysis: IGF-1 LR3 vs. Native IGF-1 and Related Variants
When designing Somatomedin-focused assays, investigators often compare IGF-1 LR3 against related variants within the growth factor family. Native IGF-1 provides baseline physiological kinetics but suffers from rapid inactivation in serum-containing media due to high-affinity binding to IGFBPs. Conversely, truncations such as IGF-1 DES lack the first three N-terminal amino acids, yielding extreme potency in localized, low-pH cellular microenvironments but possessing a very short systemic half-life.
In contrast to short-acting analogs, IGF-1 LR3 balances high biological activity with an extended half-life, making it ideal for multi-day in vitro assays and systemic rodent protocols. Furthermore, researchers investigating myogenesis and tissue remodeling frequently compare or combine IGF-1 receptor ligands with mechano-sensitive peptides like PEG-MGF to differentiate between initial satellite cell activation and subsequent protein translation phases. Understanding these distinct pharmacokinetic profiles enables investigators to choose the optimal research compound for their specific endpoint requirements.
Assay Methodologies and Experimental Endpoint Quantification
To quantify the bioactivity and mechanistic pathways of IGF-1 LR3, laboratories utilize a range of analytical assays. Western blotting is commonly employed to measure the phosphorylation state of key proteins within the MAPK/ERK and PI3K/Akt/mTOR axes. Scientists track ratio shifts between total Akt and phosphorylated Akt (p-Akt Ser473) following peptide exposure across various time points.
For quantitative mRNA expression analysis, quantitative reverse-transcription PCR (qPCR) is utilized to assess transcript upregulation of myogenic regulatory factors (e.g., MyoD, Myf5) or hypertrophic marker genes. Additionally, flow cytometry and 5-bromo-2'-deoxyuridine (BrdU) incorporation assays allow researchers to precisely measure cell cycle progression and DNA synthesis rates in cells treated with varying concentrations of high-purity research peptides.
Laboratory Reconstitution and Handling Protocols
Proper reagent handling is critical to ensure experimental reproducibility and maintain peptide integrity. IGF-1 LR3 is supplied as a lyophilized (freeze-dried) powder that requires careful reconstitution before introduction into culture media or buffer solutions. Laboratories typically reconstitute the lyophilized powder using dilute organic acids, such as 10 mM to 100 mM acetic acid, to achieve full solubilization prior to dilution in sterile phosphate-buffered saline (PBS) or culture media containing carrier proteins like bovine serum albumin (BSA).
Direct reconstitution in neutral pH buffers without a primary acidic solubilization step can lead to peptide aggregation or precipitation. To assist research staff in calculating precise solvent volumes and final working concentrations for volumetric micro-pipetting, laboratories can utilize the PX1 Research reconstitution calculator. Reconstituted stock solutions should be aliquoted into single-use polypropylene tubes to prevent repeated freeze-thaw cycles, which degrade the tertiary structure of the protein.
Analytical Standards: Purity Verification and Quality Control
The reliability of in vitro and in vivo research outcomes depends directly on the chemical purity and structural integrity of the synthesized peptide. Minor contaminants, such as residual truncated peptide sequences, trifluoroacetic acid (TFA) salts, or bacterial endotoxins, can alter cellular signaling outcomes and introduce confounding variables into sensitive assays.
PX1 Research ensures that every batch of synthetic peptide undergoes rigorous quality control within ISO 17025 accredited testing facilities. Analytical verification includes High-Performance Liquid Chromatography (HPLC) to confirm chemical purity (>98%) and Mass Spectrometry (MS) to verify precise molecular weight. Furthermore, bacterial endotoxin testing (LAL assay) is conducted to ensure low endotoxin levels suitable for cell culture and preclinical administration. Every shipment includes access to a lot-specific Certificate of Analysis (COA), giving researchers full verification of reagent quality.
Storage Recommendations and Reagent Stability
To preserve long-term potency, lyophilized IGF-1 LR3 should be stored in a commercial freezer at -20°C or -80°C, protected from light and moisture. Under these conditions, the lyophilized peptide remains stable for extended periods without significant degradation of sequence integrity. Desiccant packs should be kept in the storage container to prevent humidity accumulation upon thawing.
Once reconstituted in an appropriate acidic stock solution (e.g., 0.1% acetic acid with 0.1% BSA), aliquots can be stored at 2°C to 8°C for short-term experimental work (up to 2-3 weeks). For long-term storage of reconstituted solutions, aliquots must be frozen at -80°C. For institutional procurement departments seeking reliable supply chains and volume pricing for ongoing research protocols, PX1 Research provides dedicated wholesale accounts backed by fast, domestic dispatch from USA facilities in California and Arizona.
Frequently Asked Questions
What is IGF-1 LR3 primary used for in preclinical research?
IGF-1 LR3 is used primarily to study IGF-1 receptor kinetics, intracellular signal transduction (PI3K/Akt/mTOR pathways), cellular proliferation, and myoblast differentiation in cell cultures and animal models without interference from IGF-binding proteins.
How does IGF-1 LR3 differ structurally from native IGF-1?
IGF-1 LR3 features a substitution of glutamic acid with arginine at position 3 and a 13-amino-acid extension at the N-terminus, totaling 83 amino acids compared to native IGF-1's 70 amino acids.
Why is reduced IGFBP binding advantageous in cell culture research?
Reduced affinity for IGF-binding proteins prevents the peptide from being sequestered or neutralized by serum proteins in media, resulting in higher free ligand availability and prolonged biological activity.
What solvent should be used to reconstitute lyophilized IGF-1 LR3?
Lyophilized IGF-1 LR3 is typically reconstituted first in a dilute acid solution (such as 10-100 mM acetic acid) to ensure complete dissolution, followed by further dilution in PBS containing 0.1% BSA as a carrier protein.
How does PX1 Research verify the purity of IGF-1 LR3?
PX1 Research verifies every lot using High-Performance Liquid Chromatography (HPLC) for purity determination, Mass Spectrometry (MS) for identity validation, and Limulus Amebocyte Lysate (LAL) testing for endotoxin levels in ISO 17025 accredited testing facilities.
What is the recommended storage temperature for IGF-1 LR3?
Lyophilized powder should be stored at -20°C or -80°C away from light and moisture. Reconstituted acidic stock aliquots can be stored at 2°C to 8°C for short-term use or frozen at -80°C for long-term storage.
Can IGF-1 LR3 be used for human or clinical research?
No. IGF-1 LR3 supplied by PX1 Research is strictly designated for laboratory in vitro and preclinical research use only. It is not intended or approved for human, clinical, or veterinary applications.
What cell lines are typically used in IGF-1 LR3 in vitro studies?
Common cell lines include C2C12 murine myoblasts for skeletal muscle research, primary chondrocytes, cardiac myocytes, and various progenitor cell types evaluating proliferative and anti-apoptotic signaling.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.